Dr Frank Waldron-Lynch is a physician scientist and is an honorary fellow of the Experimental Medicine and Immunotherapeutics Team at The University of Cambridge. He is also an Honorary Consultant Endocrinologist at the Cambridge University Hospitals NHS Foundation Trust was principal investigator for the 'DILT1D' and 'DILfrequency' type 1 diabetes clinical research studies which investigated novel immunotherapy for the disease. His current research interests are in the area of Translational Immunology and autoimmunity. Please see this link for more information about the research Frank is involved with. Contact Frank at CamT1D@medschl.cam.ac.uk or by calling +44 (0)1223 762327.
I am a research nurse and coordinator working in the Department of Clinical Biochemistry part of the Metabolic Research Laboratories here at the University of Cambridge and I have been working on type 1 diabetes and metabolic studies alongside Dr Mark Evans & Dr Waldron-Lynch for about 5 years. I also facilitate the CAMEO patient support group for newly diagnosed patients and am happy to help with any questions you may have regarding our research, how to take part and what we are up to at Cambridge. You can read more about my work on a day to day basis here. Contact me on CamT1D@medschl.cam.ac.uk or +44 (0) 1223 762327.
I am a part time study coordinator working on many of the adult type 1 diabetes and metabolic clinical research studies as part of the CamT1D team. I have qualifications in health service management and many years’ experience of research in the academic and health care setting. I have worked with the Artificial Pancreas studies and now a key member of the T1D team, helping to support the participants and study team with administrative and logistical tasks. I am happy to answer your queries or questions relating to trials and clinical studies. Feel free to contact me on CamT1D@medschl.cam.ac.uk or by calling +44 (0)1223 762327.
Dr Simon Bond MA PhD CStat CSci leads the statistics team within Cambridge Clinical Trials Unit, providing advice and services to all phases of trials from initial planning to final analysis and dissemination. He has research interests in early phase and adaptive trial design.
Dr Adrian Mander is the director of the MRC Biostatistics Unit Hub for Trials Methodology Research and leads a programme of research in adaptive clinical trial design. He has been working in area of statistics within clinical trials for over 20 years both in a public sector setting and within a large pharmaceutical company. The emphasis of his work is to translate developments in trial design into practice.
Mark Evans is a Clinical Lecturer and Researcher at The Institute of Metabolic Science, University of Cambridge and Honorary Consultant Physician at Cambridge University Hospitals NHS Foundation Trust. He specialises in the treatment of type 1 diabetes and is involved in research of novel therapies as well as novel medical devices. Mark can be contacted via the contact us page or calling +44 (0)1223 762327.
I am a Surgeon-Scientist and Clinical Fellow in Experimental Medicine and ENT Surgery. My specific research interest is in autoimmune inflammation, lymphoid tissue organisation in Type 1 Diabetes and Sjögren’s syndrome. I have previously been involved with clinical trials for type 1 diabetes, chronic otitis media, Sjögren’s syndrome and neurosurgery. My clinical speciality is Otolaryngology and Head and Neck Surgery.
Dr Eleonora Seelig is a clinical fellow at the University of Cambridge and is also a Consultant Endocrinologist. She is here in Cambridge on behalf of the Swiss National Research Foundation and has worked on numerous metabolic clinical studies including DILfrequency and the Genetics of Obesity studies in the Institute of Metabolic Science.